Therapeutic Agent Formulations For Implanted Devices
US-2017258634-A1 · Sep 14, 2017 · US
US12343283B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12343283-B2 |
| Application number | US-202217745007-A |
| Country | US |
| Kind code | B2 |
| Filing date | May 16, 2022 |
| Priority date | Jul 15, 2014 |
| Publication date | Jul 1, 2025 |
| Grant date | Jul 1, 2025 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
An ocular implant system including an ocular implant sized and shaped to be inserted at least partially into an eye; a carrier member with a shell having a central channel extending at least partially through the shell from a proximal end towards a distal end of the shell. A guide sleeve removably attached within at least a first region of the central channel of the shell and defining a proximal port into the central channel that is accessible from the proximal end of the shell. An implant holder removably attached within at least a second region of the central channel of the shell adjacent to a distal end of the guide sleeve and having a pair of graspers adapted to releasably secure the implant at a distal end of the implant holder. Related devices, systems, and/or methods are described.
Opening claim text (preview).
What is claimed: 1. An ocular implant handling system, comprising: a shell of a carrier member comprising a central channel extending at least partially through an upper surface of the shell along a longitudinal axis from a proximal end of the shell towards a distal end region of the shell, a proximal port into the central channel being located at the proximal end of the shell, wherein the shell defines an opening near the distal end region of the shell that extends through the upper surface of the shell and through a lower surface of the shell; and an implant holder removably attached to the shell, wherein an interior of the implant holder is arranged coaxial with the central channel and having a distal end positioned within the opening. 2. The system of claim 1 , further comprising a fill needle assembly having a fill needle and a luer configured to couple to a syringe. 3. The system of claim 2 , wherein the fill needle assembly is sized and shaped for insertion into the central channel towards the implant holder. 4. The system of claim 2 , wherein the interior of the implant holder is sized to receive at least a portion of fill needle assembly. 5. The system of claim 1 , wherein the system further comprises an ocular drug delivery implant, the implant having a distal end region positioned within the opening and a proximal end region grasped by the distal end of the implant holder. 6. The system of claim 5 , wherein the implant comprises a proximal retention structure having a fill port, a reservoir, and a porous element in fluid communication with the reservoir at the distal end region, at least a portion of the implant is sized and shaped to be inserted into an eye such that the implant delivers the one or more therapeutic agents from the reservoir into the eye through the porous element. 7. The system of claim 5 , further comprising a handle member usable for inserting the implant into the eye, the handle member comprising an elongated proximal portion and a distal attachment portion, wherein the implant holder is configured to interchangeably couple with the shell and the distal attachment portion of the handle member. 8. The system of claim 7 , wherein the distal attachment portion of the handle member is sized and shaped to be inserted through the central channel so as to releasably attach to the implant holder holding the implant. 9. The system of claim 6 , wherein the distal end of the implant is visible to a user through the opening during filling of the implant with a liquid using a fill needle inserted through the fill port.
Ophthalmic product dispenser attachments to facilitate positioning near the eye · CPC title
Ocular inserts or implants · CPC title
Methods or devices for eye surgery · CPC title
Devices for introducing or retaining media, e.g. remedies, in cavities of the body (A61M25/00 takes precedence {; introducing or retaining ophthalmic products into the ocular cavities A61F9/0008}) · CPC title
implantable in, or in contact with, the eye, e.g. ocular inserts · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.